SEC Comment Letter 0000000000-26-001510 to BiomX Inc. (PHGE)
BiomX Inc.
Date: Feb. 12, 2026 · CIK: 0001739174 · Accession: 0000000000-26-001510
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293308
Letter
February 12, 2026 Jonathan Solomon Chief Executive Officer BiomX Inc. 708 Quince Orchard Rd, Suite 205 Gaithersburg, MD 20878 Re:BiomX Inc. Registration Statement on Form S-3 Filed February 9, 2026 File No. 333-293308 Dear Jonathan Solomon: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Sara Lee, Esq.
Show Raw Text
February 12, 2026
Jonathan Solomon
Chief Executive Officer
BiomX Inc.
708 Quince Orchard Rd, Suite 205
Gaithersburg, MD 20878
Re:BiomX Inc.
Registration Statement on Form S-3
Filed February 9, 2026
File No. 333-293308
Dear Jonathan Solomon:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Sara Lee, Esq.